News

The mystery for this 21-year-old patent was not that he had fibrodysplasia ossificans progressiva, but that he'd lived so ...
From new partnerships and launches, here are six developments from Globus Medical so far in 2025. 1. OsteoCentric Technologies entered into a non-exclusive licensing agreement with Globus Medical.
Globus Medical, Inc. (NYSE: GMED) announced that its Board of Directors has authorized a share repurchase program of up to ...
LSU Health Shreveport Department of Neurosurgery hosted a surgical skills workshop for medical students, giving them a ...
Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 ...
Globus Medical’s board of directors authorized a share repurchase program of up to $500 million of the company’s outstanding common stock. Timing and number of repurchased shares will be determined by ...
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors ...